Connor, Clark & Lunn Investment Management (CC&L)
LOGC

Connor, Clark & Lunn Investment Management (CC&L)’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio LOGC Stock Details LOGC Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,974
Closed -$25K – 1280
2021
Q4 		$25K Buy
+10,974
New +$25K ﹤0.01% 1053